FAST-Forward 淋巴结亚组:乳腺癌术后放疗手臂肿胀相关因素
该研究基于 FAST-Forward 淋巴结亚组 469 例患者,分析患者、肿瘤和治疗因素与 5 年手臂/手肿胀的关联。多因素分析显示腋窝淋巴结清扫(ALND)和 BMI≥35 kg/m2 是患者报告中度/明显手臂/手肿胀的显著预测因素,ALND 和阳性淋巴结数量是临床医生报告手臂淋巴水肿的显著预测因素;未发现单个剂量学参数与 5 年手臂肿胀显著相关。
要点
- ALND 与 5 年患者报告手臂/手肿胀显著相关(OR 3.70)。
- BMI≥35 kg/m2 是患者报告手臂/手肿胀显著预测因素(OR 3.31)。
- 未发现单个剂量学参数与 5 年手臂肿胀显著相关。
核心结论
- 腋窝手术仍是淋巴结阳性乳腺癌局部区域放疗后长期手臂淋巴水肿的主要预测因素,支持降级 ALND 以降低该风险。
研究设计与样本
- FAST-Forward 随机淋巴结亚组后续分析,纳入 469 例接受辅助乳腺/胸壁及腋窝放疗的患者,前瞻性收集 DICOM-RT 数据并回顾性勾画腋窝淋巴结 1-4 站、腋窝-胸外侧血管交汇处(ALTJ)和可见血清肿。
主要发现
- 5 年时 39/299(13%)患者报告中度/明显手臂/手肿胀,45/346(13%)临床医生报告手臂淋巴水肿。
- 多因素分析中 ALND(OR 3.70,95%CI 1.61-8.48,p=0.002)和 BMI≥35 kg/m2(OR 3.31,95%CI 1.08-10.12,p=0.036)是 5 年患者报告中度/明显手臂/手肿胀的显著预测因素。
- 多因素分析中 ALND(OR 3.67,95%CI 1.55-8.69,p=0.003)和阳性淋巴结数量(OR 1.08,95%CI 1.00-1.18,p=0.049)是 5 年临床医生报告手臂淋巴水肿的显著预测因素。
- 多因素分析未发现单个剂量学参数与 5 年手臂肿胀之间存在显著关联。
临床怎么用
- 对于淋巴结阳性乳腺癌患者,应关注 ALND 和高 BMI 对长期手臂淋巴水肿风险的影响,并支持在适当情况下降级 ALND。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE/OBJECTIVE: The FAST-Forward randomised nodal sub-study primary analysis showed non-inferiority for 5-year patient-reported arm/hand swelling following adjuvant breast/chest wall and axillary radiotherapy given in 26 Gy in 5 fractions (Fr) over 1 week compared to 40 Gy in 15Fr over 3 weeks. This subsequent analysis investigates the association between patient, tumour and treatment factors and development of long-term arm/hand swelling. MATERIAL/METHODS: Data from 469 patients randomised to adjuvant radiotherapy 40 Gy/15Fr, 27 Gy/5Fr or 26 Gy/5Fr to breast/chest wall and axilla (any or all levels 1-4) in the FAST-Forward nodal sub-study were included. DICOM-RT data were collected prospectively. ESTRO-defined axillary nodal levels 1-4, the axillary-lateral thoracic vessel juncture (ALTJ), and visible seroma were contoured retrospectively. Mean, maximum and minimum doses were extracted. Univariable and stepwise multivariable logistic regression were used to identify predictors of 5-year arm swelling. RESULTS: At 5 years, moderate/marked arm/hand swelling was reported by 39/299 (13%) patients and clinician-reported arm lymphoedema by 45/346 (13%). Multivariable analysis identified axillary lymph node dissection (ALND) (OR 3.70, 95% CI [1.61-8.48], p = 0.002) and BMI ≥ 35 kg/m2 (OR 3.31 [1.08-10.12], p = 0.036) as significant predictors of 5-year patient-reported moderate/marked arm/hand swelling. For 5-year clinician-reported arm lymphoedema, multivariable analysis identified ALND (OR 3.67 [1.55-8.69], p = 0.003) and number of positive lymph nodes (OR 1.08 [1.00-1.18], p = 0.049) as significant predictors. No significant associations were found between individual dosimetric parameters and 5-year arm swelling on multivariable analysis. CONCLUSION: Axillary surgery remains the main predictor of long-term arm lymphoedema following locoregional radiotherapy for node-positive breast cancer, supporting de-escalation of ALND to reduce this risk.
引用
- Ravindra S, Cafferty FH, Harris E, et al. Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study. Radiother Oncol. 2026. PMID: 42067068. doi:10.1016/j.radonc.2026.111547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。